Chapter 3 82 Ehrensperger, M. M. et al. (2010) ‘Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer’s disease’, International Psychogeriatrics. Cambridge University Press, 22(1), pp. 91–100. doi: 10.1017/S1041610209990962. Ferri, C. P. et al. (2005) ‘Global prevalence of dementia: A Delphi consensus study’, Lancet, 366(9503), pp. 2112–2117. doi: 10.1016/S0140-6736(05)67889-0. Freitas, S. et al. (2012) ‘Montreal cognitive assessment: Influence of sociodemographic and health variables’, Archives of Clinical Neuropsychology. doi: 10.1093/arclin/acr116. Gauthier, S. et al. (2006) ‘Mild cognitive impairment’, Lancet, pp. 1262–1270. doi: 10.1016/S01406736(06)68542-5. Gil, L. et al. (2015) ‘Validation of the Montreal Cognitive Assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia’, International Journal of Geriatric Psychiatry, 30(6), pp. 655–662. doi: 10.1002/gps.4199. Gorelick, P. B. et al. (2011) ‘Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association’, Stroke, 42(9), pp. 2672–2713. doi: 10.1161/STR.0b013e3182299496. Gorno-Tempini, M. L. et al. (2011) ‘Classification of primary progressive aphasia and its variants.’, Neurology. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology, 76(11), pp. 1006–14. doi: 10.1212/WNL.0b013e31821103e6. De Jonghe, J. F. M. (1997) ‘Differentiating between demented and psychiatric patients with the Dutch version of the IQCODE’, International Journal of Geriatric Psychiatry, 12(4), pp. 462–465. doi: 10.1002/ (SICI)1099-1166(199704)12:4<462::AID-GPS510>3.0.CO;2-Q. Larouche, E. et al. (2016) ‘Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People’, Archives of Clinical Neuropsychology, 31(7), pp. 819–826. doi: 10.1093/ arclin/acw076. Lee, J. Y. et al. (2008) ‘Brief screening for mild cognitive impairment in elderly outpatient clinic: Validation of the Korean version of the Montreal Cognitive Assessment’, Journal of Geriatric Psychiatry and Neurology, 21(2), pp. 104–110. doi: 10.1177/0891988708316855. Lin, J. S. et al. (2013) ‘Screening for Cognitive Impairment in Older Adults: A Systematic Review for the U.S. Preventive Services Task Force’, Annals of Internal Medicine. American College of Physicians, 159(9), pp. 601–612. doi: 10.7326/0003-4819-159-9-201311050-00730. McKeith, I. G. et al. (2005) ‘Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.’, Neurology. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology, 65(12), pp. 1863–72. doi: 10.1212/01.wnl.0000187889.17253.b1. McKhann, G. M. et al. (2011) ‘The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.’, Alzheimer’s & dementia : the journal of the Alzheimer’s Association. Elsevier, 7(3), pp. 263–9. doi: 10.1016/j.jalz.2011.03.005. Memõria, C. M. et al. (2013) ‘Brief screening for mild cognitive impairment: Validation of the Brazilian version of the Montreal cognitive assessment’, International Journal of Geriatric Psychiatry. doi: 10.1002/gps.3787. Mitchell, A. J. (2009) ‘A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment’, Journal of Psychiatric Research, 43(4), pp. 411– 431. Available at: https://doi.org/10.1016/j.jpsychires.2008.04.014.
RkJQdWJsaXNoZXIy MTk4NDMw